Literature DB >> 825036

In vitro susceptibility of gentamicin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to netilmicin and selected aminoglycoside antibiotics.

R D Meyer, L L Draus, K A Pasieczinik.   

Abstract

Netilmicin (Sch 20569), a semisynthetic aminoglycoside related to gentamicin C(1a), was evaluated in vitro in agar dilution testing against 224 different clinical isolates of gentamicin-resistant Enterobacteriaceae and Pseudomonas aeruginosa in parallel with amikacin, gentamicin, sisomicin, and tobramycin. Netilmicin showed a very high degree of activity against gentamicin-resistant organisms, but amikacin was more active in vitro, particularly against Providencia stuartii and P. aeruginosa. Sisomicin and tobramycin were consistently less active than either netilmicin or amikacin. Netilmicin was bactericidal in broth testing against P. aeruginosa. Netilmicin showed a greater difference between results with agar and broth dilution testing than did amikacin.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 825036      PMCID: PMC429813          DOI: 10.1128/AAC.10.4.677

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  17 in total

1.  Activity of three aminoglycosides and two penicillins against four species of gram-negative bacilli.

Authors:  R J Weinstein; L S Young; W L Hewitt
Journal:  Antimicrob Agents Chemother       Date:  1975-02       Impact factor: 5.191

2.  Infections caused by Providence bacilli.

Authors:  J Klastersky; A M Bogaerts; J Noterman; E van Laer; D Daneau; E Mouawad
Journal:  Scand J Infect Dis       Date:  1974

Review 3.  Mechanisms of antibiotic resistance in bacteria.

Authors:  R Benveniste; J Davies
Journal:  Annu Rev Biochem       Date:  1973       Impact factor: 23.643

4.  Antibiotic susceptibility testing by a standardized single disk method.

Authors:  A W Bauer; W M Kirby; J C Sherris; M Turck
Journal:  Am J Clin Pathol       Date:  1966-04       Impact factor: 2.493

5.  Antibiotic susceptibility of gram-negative bacilli isolated from blood cultures. Results of tests with 35 agents and strains from 169 patients at Boston City Hospital during 1972.

Authors:  J E McGowan; C Garner; C Wilcox; M Finland
Journal:  Am J Med       Date:  1974-08       Impact factor: 4.965

6.  Effect of salt concentration on the apparent in-vitro susceptibility of Pseudomonas and other gram-negative bacilli to gentamicin.

Authors:  A A Medeiros; T F O'Brien; W E Wacker; N F Yulug
Journal:  J Infect Dis       Date:  1971-12       Impact factor: 5.226

7.  Emergence of resistance of Providencia stuartii to multiple antibiotics: speciation and biochemical characterization of Providencia.

Authors:  G D Overturf; J Wilkins; R Ressler
Journal:  J Infect Dis       Date:  1974-03       Impact factor: 5.226

8.  Gentamicin-resistant Pseudomonas aeruginosa and Serratia marcescens in a general hospital.

Authors:  R D Meyer; R P Lewis; J Halter; M White
Journal:  Lancet       Date:  1976-03-13       Impact factor: 79.321

9.  Susceptibility of Pseudomonas aeruginosa to gentamicin sulfate in vitro: lack of correlation between disc diffusion and broth dilution sensitivity data.

Authors:  W H Traub
Journal:  Appl Microbiol       Date:  1970-07

10.  Activity of five aminoglycoside antibiotics in vitro against gram-negative bacilli and Staphylococcus aureus.

Authors:  L S Young; W L Hewitt
Journal:  Antimicrob Agents Chemother       Date:  1973-12       Impact factor: 5.191

View more
  16 in total

1.  Correlation of netilmicin agar dilution and disk diffusion susceptibilities.

Authors:  D A Goldmann; G P Syriopoulou; A M Semple
Journal:  Antimicrob Agents Chemother       Date:  1977-08       Impact factor: 5.191

2.  Clinical and bacteriological evaluation of netilmicin in gram-negative infections.

Authors:  J Klastersky; F Meunier-Carpentier; L Coppens-Kahan; D Daneau; J M Prevost
Journal:  Antimicrob Agents Chemother       Date:  1977-10       Impact factor: 5.191

3.  Outbreak of multiply drug-resistant Proteus mirabilis originating in a surgical intensive care unit: in vitro susceptibility pattern.

Authors:  T T Yoshikawa; S A Shibata; A W Chow; L B Guze
Journal:  Antimicrob Agents Chemother       Date:  1978-02       Impact factor: 5.191

4.  Serotypes of Pseudomonas aeruginosa in clinical specimens in relation to antibiotic susceptibility.

Authors:  N J Legakis; M Aliferopoulou; J Papavassiliou; M Papapetropoulou
Journal:  J Clin Microbiol       Date:  1982-09       Impact factor: 5.948

5.  Frequency of resistance to kanamycin, tobramycin, netilmicin, and amikacin in gentamicin-resistant gram-negative bacteria.

Authors:  S J Seligman
Journal:  Antimicrob Agents Chemother       Date:  1978-01       Impact factor: 5.191

6.  Prospective comparative study of efficacy and toxicity of netilmicin and amikacin.

Authors:  B V Bock; P H Edelstein; R D Meyer
Journal:  Antimicrob Agents Chemother       Date:  1980-02       Impact factor: 5.191

7.  In vitro susceptibility studies with netilmicin: comparison of a 10-microgram netilmicin disk with a standardized 10-microgram gentamicin disk.

Authors:  V Habwe; S Shadomy
Journal:  Antimicrob Agents Chemother       Date:  1978-06       Impact factor: 5.191

8.  Comparison of netilmicin with gentamicin in the therapy of experimental Escherichia coli meningitis.

Authors:  W M Scheld; R S Brown; M A Sande
Journal:  Antimicrob Agents Chemother       Date:  1978-06       Impact factor: 5.191

9.  Netilmicin: clinical efficacy, tolerance, and toxicity.

Authors:  A P Panwalker; J B Malow; V M Zimelis; G G Jackson
Journal:  Antimicrob Agents Chemother       Date:  1978-02       Impact factor: 5.191

10.  In vitro studies with netilmicin compared with amikacin, gentamicin, and tobramycin.

Authors:  V Dhawan; E Marso; W J Martin; L S Young
Journal:  Antimicrob Agents Chemother       Date:  1977-01       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.